Skip to main contentSkip to navigation
Sirius Investors
Winston Pharmaceuticals, Inc.

Winston Pharmaceuticals, Inc.

WPHM
OTC•Healthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for WPHM. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Quick links:Overview•Financial Metrics•Technicals•Returns•Financials•Performance

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
5.51M
97.3x increase over period
CAGR: +193.26%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
3.95M
17.4x increase over period
CAGR: +95.63%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Mar 31, 2010

EV/EBITDA

Distorted

-13.69x

Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.

EV vs Market Cap Spread

-1.56M

EV is -28.3% vs equity value

Capital Structure Signal

Net Cash Profile

EV premium trend: -329.5 pp vs earliest data

Additional Multiples

EV/Sales: 19.86x

Net Debt/EBITDA: 1.47x

Share count change in dataset: +9629.00%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Dec 31, 20095.51M3.95M$0.0961.26M
Dec 31, 20084.81M-818.92K$0.0953.42M
Sep 30, 2007148.43K-4.33M$0.091.65M
Sep 30, 2006
————
Sep 30, 2005
————

Enterprise Value Analysis

Price Change (Dec 2008 to Dec 2009)

The stock price has decreased from Dec 2008 to Dec 2009.
0.00%

Recent Volatility

The stock price has been relatively stable over the last 5 periods, indicating a lower risk profile.
0.00

Risk-Adjusted Return

The stock's returns compensate somewhat for its risk, suggesting a moderate investment opportunity.
0.00

Market Cap Change (Dec 2008 to Dec 2009)

The company's market capitalization has increased from Dec 2008 to Dec 2009.
+14.67%

Enterprise Value Change (Dec 2008 to Dec 2009)

The company's enterprise value has decreased from Dec 2008 to Dec 2009, suggesting a decline in the company's total economic value.
-582.39%

Market Cap vs. Enterprise Value

A lower enterprise value growth rate compared to market cap growth could suggest that the company is reducing debt or increasing cash reserves.
Market Cap Growth > EV Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (5 periods), accounting for compounding effects.
193.26%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (5 periods), accounting for compounding effects.
95.63%